Telix Pharmaceuticals Limited (NASDAQ: TLX) reported FY Revenue at AU$783.2 million.

GUIDANCE:

Telix Pharmaceuticals Limited sees FY2025 revenue of $770-800 million, versus the consensus of $748.3 million.

For earnings history and earnings-related data on Telix Pharmaceuticals Limited (TLX) click here.